A Population-Based Clinical Trial of Irinotecan and Carboplatin

Table 2

Patient characteristics.

Number of patients	50
Male/female	27/23
Age (yr)
range	35–83
Median	61
Performance status
0	12
1	35
2	3
Number of previous chemotherapies
1	25
2	20
3	5
Tumor types
Nonsmall-cell lung	21
Small-cell lung	10
Gastrointestinal	10
Head/neck	3
Miscellaneous	6